| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 20,500 | 20 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals, Inc. | 20 Feb 2024 | 1 | $0 | 4 | Director | 22 Feb 2024, 16:16 |
| SLRX | Salarius Pharmaceuticals, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 17:03 |
| SLRX | Salarius Pharmaceuticals, Inc. | 20 Jan 2022 | 1 | $0 | 4 | Director | 21 Jan 2022, 15:05 |